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Abstract
Background: IAPP1-37 and ProIAPP1-48 are amyloidogenic peptides implicated in β-cell death in diabetes. 
Interactions with metals may be involved in both the cytotoxicity of these peptides and their deposition as 
amyloids associated with diabetes-related pathologies. 
Methods: We have used the complementary methods of thioflavin T (ThT) fluorescence and transmission 
electron microscopy (TEM) to investigate the role of seeds and specifically metal-peptide seeds in 
accelerating amyloid formation by ProIAPP. In addition we have used these complementary methods 
alongside dynamic light scattering (DLS) to observe the dynamics of IAPP amyloid formation during the 
earliest phase of peptide aggregation.
Results: Seeding universally resulted in an acceleration of amyloid formation, as indicated by increased ThT 
fluorescence, over the shorter term (minutes) while having no influence upon total amyloid deposits (no 
differences in ThT fluorescence) over many days. Only copper-peptide seeds were ineffective in accelerating 
amyloid formation above that observed for sham seeds (no peptide). Different seeding environments resulted 
in amyloid deposits of different fibrillar and non-fibrillar morphologies following longer term incubations 
regardless of the uniform nature of the respective measurements of ThT fluorescence. The aggregation 
dynamics of IAPP, mimicking its secretion into extracellular milieus, were complex and suggested 
that while metals at equimolar, generally increased rates of aggregation, with the possible exception of 
Cu(II), the range of sub-micron and micron-sized particles observed were not easily explained by either 
measurement of ThT fluorescence or imaging by TEM. 
Conclusions: Seeding may be significant in accelerating the formation of amyloid and in influencing the 
final morphologies of deposited amyloids but not in determining the total deposits of amyloid. It was of 
interest that copper-peptide seeds did not accelerate amyloid formation in the shorter term and this could 
indicate an incompatible seeding morphology due to copper? This first attempt to monitor aggregation 
dynamics of IAPP over only minutes has shown direct impact of metals on peptide particle size which could 
have implications for the cytotoxicity of IAPP in diabetes.
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Background
Amyloids derived from a burgeoning number of different 
peptides and proteins have been implicated in the aetiolo-
gies of human disease including neurodegenerative diseases, 
heart disease and diabetes [1]. In diabetes the peptides IAPP 
and ProIAPP are known to be amyloidogenic and are linked 
with cytotoxicity of β cells in the islets of Langerhans in the 
pancreas [2]. A universal mystery in amyloidogenesis is how 
amyloids form in vivo when the concentrations in extracellular 
milieus of their peptide or protein precursors are consistently 
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below saturation. The role of metals in catalysing amyloido-
genesis has been studied extensively and the propensities 
for both IAPP [3] and ProIAPP [4] to form amyloid β sheets 
are significantly influenced by metals. While the evidence is 
quite clear that Cu(II) prevents both IAPP and ProIAPP from 
forming amyloid β sheets the data pertaining to Al(III), Fe(III) 
and Zn(II) remains equivocal as to whether they promote or 
have little influence upon the formation of amyloid β sheets 
[3-8]. All metals do affect the morphologies of amyloid-like 
materials [4] and there are also suggestions that the subse-
quent aggregation of such materials towards precipitated 
solids is influenced by metals [9].
When IAPP and ProIAPP are released into extracellular 
milieus in vivo they are secreted as vesicle concentrates which 
will then dilute into the extracellular environment. Herein 
we have looked to mimic these conditions in vitro and to 
follow the subsequent dilution of peptide concentrates into 
extracellular fluids and thereafter their aggregation towards 
fibrillar and non-fibrillar deposits.
Methods
IAPP and ProIAPP1-48 (no C-terminal fragment) were synthe-
sised by standard FMOC-based solid phase methods using 
an Applied Biosystems 433A synthesiser and purified by RP 
HPLC using water/acetonitrile mixtures buffered with 0.1% 
TFA on a POROS 20R2 column. Peptide content was con-
firmed by quantitative amino acid analysis and lyophilised 
peptide stored at -80°C until required. Thawed peptides 
were dissolved in ultra-pure water (conductivity <0.067 µS/
cm) to give peptide stocks of ca 200 µM. Peptide stocks were 
diluted into modified Krebs-Henseleit medium buffered at 
pH 7.40±0.05 [10] to give the required treatments and all 
assays and incubations were at 37°C. Metals were added 
from certified stock solutions (Perkin-Elmer, UK) prior to 
addition of peptide stocks. Similarly, citrate (1.0 mM) was 
added from a 10 mM stock of citric acid to KH media prior to 
both metals and peptides. Seeds of ProIAPP were prepared 
as equimolar solutions of peptide ± metal (75 µM) aged at 
37°C for 24h prior to their addition to 100 µL assays as 5 µL 
aliquots. All peptide-containing seeds, with the exception 
of ProIAPP-Cu(II), showed significant ThT fluorescence (>100 
AU) before their addition to assays. The presence of β sheets 
of amyloid in assays was followed by ThT fluorescence and 
TEM using established methods [10,11]. Peptide aggregation 
was followed at 37°C by dynamic light scattering (DLS) using 
the ZetaSizer NanoZS (Malvern Instruments, UK). The method 
relies upon Brownian motion to keep primarily sub-micron 
particles in suspension and measures peak intensities (%) for 
particles of diameter, nanometer (ca 1nm) to micrometer (<6 
µm). Aliquots of peptide stocks were added to prepared KH 
media without any mixing or stirring prior to the capture of 
particle size data. Only assays which gave a count rate >75 
counts per minute (cpm) and particles with intensity above 
1% were included in the collected data.
Results
Influence of the metal:peptide ratio on ThT fluorescence 
of IAPP
All treatments were mixed by brief vortexing prior to sampling 
for ThT fluorescence. The co-incubation of 5 µM IAPP with Al(III) 
for 4 days at 37°C had no significant influence (P>0.05) upon 
ThT fluorescence relative to IAPP alone (Figure 1). The pres-
ence of Zn(II) significantly (P<0.05) reduced ThT fluorescence 
relative to IAPP alone at each metal:peptide ratio, for example, 
from 77(13) for IAPP only to 51(10) in the presence of only 
1 µM added Zn(II) (Figure 1). Increasing the [Zn] up to 10 µM 
did not result in further statistically significant reductions in 
ThT fluorescence. The co-incubation of 5 µM IAPP with Cu(II) 
resulted in significant (P<0.05) reductions in ThT fluorescence 
relative to IAPP only at each metal:peptide ratio (Figure 1). For 
example, from 63(5) for IAPP only to 32(14) in the presence of 
only 1 µM added Cu(II). The latter was significantly (P<0.05) 
reduced further to 16(3) and 11(2) for [Cu] of 5 and 10 µM 
respectively. Reductions in ThT fluorescence in the presence 
of Cu(II) were significantly (P<0.05) greater than for Zn(II) for 
each metal:peptide ratio (Figure 1).
When the co-incubation of 5 µM IAPP with Al(III) was con-
tinued for 36 days at 37°C there were no significant (P>0.05) 
differences in ThT fluorescence between IAPP only and [Al] 
up to 10 µM (Figure 2). However, the addition of 10 µM Cu(II) 
to each of the treatments followed by incubation at 37°C 
for a further 24h resulted in statistically significant (P<0.05) 
reductions in ThT fluorescence for each of the metal:peptide 
ratios (Figure 2). 
Influence of metal:peptide seeds on immediate aggrega-
tion of ProIAPP 
All treatments were mixed by brief vortexing prior to sam-
pling for ThT fluorescence. When ProIAPP stock was diluted 
Figure 1. The influence of the concentration of Al(III), Zn(II) 
or Cu(II) on ThT fluorescence of a 5.0 µM IAPP preparation 
following 4d incubation at 37°C. Mean and SD are plotted, 
n=5.
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into modified KH buffer to give a final, fully mixed peptide 
concentration of 35 µM and allowed to equilibrate at 37°C 
for 600s it resulted in a steady ThT fluorescence of 19.5(11.0) 
for n=75 separate treatments. The addition of peptide/metal 
seeds to the 35 µM ProIAPP preparation resulted in statistically 
significant (P<0.05) increases in ThT fluorescence in every 
case (Figure 3). This included the control (5 µL of KH buffer) 
which following addition and mixing resulted after 600s in a 
stable ThT fluorescence of 74.5(32.1). A similar increase, up to 
Figure 2. The upper plot shows the influence of the 
concentration of Al(III) on ThT fluorescence of a 5.0 µM 
IAPP preparation after incubation at 37°C for 36d. Mean and 
SD are plotted, n=5. The lower plot shows the influence on 
ThT fluorescence of adding Cu(II) to a concentration of 10 
µM to the aged IAPP preparations and incubating them for a 
further 24h at 37°C. Mean and SD are plotted, n=5.
Figure 4. The influence of seeding on ThT fluorescence of a 10 
µM preparation of ProIAPP1-48 which had been incubated for 
48h at 37°C (T1) and following further incubation at 37°C for 
7, 14 and 49d post addition of seed (T2-4). Mean and SD are 
plotted, n=25 for T1 and n=5 for T2-4.
Figure 3. The influence of seeding (seeds labelled 1-5) on ThT 
fluorescence of a 35 µM preparation of ProIAPP1-48  
following incubation at 37°C for 600s. Mean and SD are 
plotted, n=15.
78.8(31.5), was observed for the Cu(II)/peptide seed while the 
peptide only, Zn(II)/peptide and Al(III)/peptide seeds resulted 
in statistically significant (P<0.05) higher values, 139.6(49.7), 
125.6(38.0) and 155.6(38.0) respectively. 
 
Influence of metal:peptide seeds on aggregation of 
ProIAPP over 49d 
All treatments were mixed by brief vortexing prior to sampling 
for ThT fluorescence and TEM. When ProIAPP stock was diluted 
into modified KH buffer to give a final, fully mixed peptide 
concentration of 10 µM and allowed to equilibrate at 37°C 
for 48h it resulted in a steady ThT fluorescence of 8.8(1.8) for 
n=25 separate treatments. Further incubation for 7d following 
the addition of metal:peptide seeds (or a sham seed volume 
of buffer for the no seed treatment) produced significant 
(P<0.05) increases in ThT fluorescence for all treatments ex-
cept the Cu(II)/peptide seed (Figure 4). For example, seeding 
with Al(III)/peptide resulted in ThT fluorescence of 28.7(3.1) 
while seeding with Cu(II)/peptide resulted in ThT fluorescence 
of 12.4(2.9) for n=5 replicates in each case. While the Zn(II), 
Al(III) and ProIAPP seeded treatments were all statistically 
higher (P<0.05) than either the Cu(II) or no seed treatments, 
they were not statistically different (P>0.05) from each other. 
After incubation for 14d there were no statistically significant 
(P>0.05) changes in ThT fluorescence for all treatments while 
after 49d the highest values of ThT fluorescence were observed 
in, the no seed treatment, 43.5(6.4), the Al(III)/peptide seed, 
41.1(6.0) and the peptide only seed, 37.4(4.6). The Cu(II) and 
Zn(II)/peptide seeds gave similar fluorescence values which 
were statistically lower (P<0.05) than those for the no seed 
and the Al(III)/peptide seed (Figure 4).
      TEM of the unseeded treatment at 49d showed abundant 
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negatively-stained fibrils with a mean diameter of 8.9(1.8) nm, 
n=25 (Figure 5A). TEM of the Zn(II)/peptide seeded treatment 
showed distinctive negatively-stained single (mean diameter 
10.8(3.0) nm, n=25) and double fibrils (mean diameter 15.3(3.6) 
nm, n=25) (Figure 5B). TEM of the Cu(II)/peptide seeded treat-
ment also showed negatively-stained single (mean diameter 
7.1(1.9) nm, n=25) and double fibrils (mean diameter 13.2(3.4) 
nm, n=25) as well as deposits of more amorphous positively-
stained peptide deposits (Figure 5C). TEM of the Al(III)/peptide 
seeded treatment showed only a few negatively-stained single 
fibrils (mean diameter 8.8(2.5) nm, n=25) and diffuse deposits 
of positively stained peptide deposits (Figure 5D). TEM of the 
peptide only seeded treatment showed a range of primarily 
negatively-stained fibrils. They were short, perhaps truncated, 
single fibrils (mean diameter 8.7(3.1) nm, n=25) (Figure 5E) as 
well as longer single (mean diameter 8.5(2.8) nm, n=25) and 
double fibrils (mean diameter 19.5(3.3) nm, n=25) (Figure 5F).
 
The influence of metals on IAPP aggregation over 60 
minutes
Aggregation phenomena when ca 200 µM IAPP stock was 
diluted without any prior mixing to a final assay concentration 
Figure 5A-F. Electron micrographs of 10μM ProIAPP1-48 
prepared in physiological Krebs Henseleit (KH) medium at pH 
7.40±0.05 following 49 days incubation at 37°C. Treatments 
were seeded in the absence (A) and presence of ProIAPP1-48 
includingZn(II) (B), Cu(II) (C), Al(III) (D), or no added metal 
(E & F). Asterisk indicates the position of the magnified insert 
in which dimensions for single and double fibrils are shown in 
nm. Magnification X 100 K, all scale bars 200 nm.
of 5 µM into physiologically-significant milieu which included 
metals were followed over 60min by dynamic light scattering 
(DLS), transmission electron microscopy (TEM) and ThT fluo-
rescence (first 15min. only). Note there was no prior mixing 
by vortexing or any other means for any of these preparations.
IAPP in the absence of added metal produced 3 distinct 
particle sizes (peaks) at ca 1.4, 1.6 and 2.3 µm during the first 
15min. period. There were no peaks representing peptide 
particles in the sub-micron range (Supplement Figure S1a). ThT 
fluorescence during this period showed a steady rise from ca 
50 AU at T=0 to ca 80 AU at T=15min (Supplement Figure S2a). 
TEM revealed no clear fibril-like structures during this time 
period. Over the next 15min. peaks were observed at ca 1, 
78, 570 and 900 nm and 1.2, 4.2 and 5.2 µm. Between 30 
and 45min. there were particles at 327 nm and 3.6, 4.0, 5.2 
and 5.7 µm. For the final 15 minutes there was evidence of 
disaggregation, significant peaks were observed at ca 500, 
550, 780 and 900 nm and 2.6, 3.3 and 4.2 µm. TEM revealed 
fibril-like materials (width 7.74±1.42 nm) at T=30 and 60min. 
which were not negatively stained (Figure 6A).
When these experiments were repeated in the presence 
of 1 mM added citrate and compared to data in the absence 
of citrate there were overall reductions in particle sizes and 
specifically for the period 15-45min., statistically significant 
(P<0.05) increases in ThT fluorescence, ca 150 AU at T=0 to 
200 AU at T=15min. (Supplement Figure S2a), and TEM revealed 
fibril-like structures (width 9.57±1.74 nm) at T=0 and T=30 
(Figure 6B) with the latter demonstrating negative staining. 
At T=60min. no fibril-like materials were observed.
IAPP in the presence of equimolar added Al(III) produced no 
distinct particles during the initial 15min. period (Supplement 
Figure S1a). ThT fluorescence during this period showed a 
steady rise from ca 50 AU at T=0 to ca 110 AU at T=15min. 
(Supplement Figure S2b). TEM for this period revealed fibril-like 
structures which were not negatively stained. Over the next 
15min. discrete particles of diameters 188, 327, 718 and 864 
nm were observed. After 45min. only two discrete particles 
were observed of 129 and 248 nm and during the final 15min. 
the only particles identified were 197 nm and 4.4 µm in diam-
eter (Supplement Figure S1a). Negatively-stained fibrils were 
observed by TEM at T=30min. (width 4.37±0.41 nm) (Figure 6D) 
while at T=60min. no fibril-like materials were observed.
When these experiments were repeated in the presence 
of 1 mM added citrate and compared to data in the absence 
of citrate there were no clear differences in particle size 
distributions, no significant differences in ThT fluorescence 
for T=0-15min. (Supplement Figure S2b) while TEM showed 
fibril-like structures which were not negatively-stained at 
T=0 and 30min. (width 8.98±1.82 nm) (Figure 6G).
IAPP in the presence of equimolar added Cu(II) produced, 
after 15 min., a single peak attributed to a particle size of ca 
1.0 µm in diameter (Supplement Figure S1b). ThT fluorescence 
during the same period showed a steady increase from 30 
AU at T=0 to 50 AU at T=15min. (Supplement Figure S2c) while 
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structures (width 8.81±1.03 nm) similar to those also seen 
at T=0 (Figure 6G). Over the next period, 30-60min. a wide 
range of particles were observed of diameters 0.3, 0.7, 0.8, 
1, 2, 16, 130, 164, 350, 625, 825, 948 nm and 1.2 and 4.2 µm 
(Supplement Figure S1b). At T=60min. no fibril-like structures 
were observed by TEM.
When these experiments were repeated in the presence 
of 1 mM added citrate and compared to data in the absence 
of citrate there were many larger particles observed at earlier 
time points to the extent that between 45-60min. no parti-
cles <6 µm in diameter were observed. Citrate increased ThT 
fluorescence significantly (P<0.05) to ca 150 AU at T=15min. 
(Supplement Figure S2c) while having no clear influence 
on the non-negatively-stained fibril-like structures (width 
9.13±1.35 nm) observed by TEM at T=0 and 30min. (Figure 6H). 
At T=60min. no fibril-like structures were observed by TEM.
IAPP in the presence of equimolar added Zn(II) immediately 
produced a wide range of particle sizes including diameters of 
0.5, 1, 544, 686 and 948 nm and 1.3 and 1.7 µm (Supplement 
Figure S1c). ThT fluorescence during this initial 15min. period 
increased slowly from ca 30 AU to 80AU (Supplement Figure 
S2d) while non-negatively-stained fibril-like structures were 
observed by TEM. A similarly wide range of particle diameters 
were also evident after 30min. including, 0.4, 0.9, 1, 570, 600, 
690, 825 and 990 nm and 1.1, 1.3, 1.7, 2.6 and 3.6 µm. Between 
30-45min. particles of diameters 0.2, 0.3, 0.8, 136, 149, 718 
and 992 nm and 4.0 µm were observed. During the final 
15min. period particles were observed of diameters 0.7, 0.8, 
1.0, 260 and 452nm and 2.2, 2.9, 4.6 and 4.8 µm (Supplement 
Figure S1c). Non-negatively-stained fibril-like structures 
(width 9.05±1.87 nm) were observed at T=30 and T=60min. 
by TEM (Figure 6I). 
When these experiments were repeated in the presence 
of 1 mM added citrate and compared to data in the absence 
of citrate the particle size distribution data indicated either 
overall reductions in the size of particles or their aggrega-
tion towards particle diameters >6.0 µm. The non-significant 
(P>0.05) increase in ThT fluorescence at T=15min. from ca 80 
AU to 140 AU (Supplement Figure S2d) might favour the latter 
while TEM showing negatively-stained fibrils at T=0 (Figure 6J) 
and T=30min. and non-negatively stained fibril-like structures 
at T=60min. would also support this.
IAPP in the presence of equimolar added Fe(III) at T=15min. 
resulted in just one single discrete particle of 825 nm diameter 
(Supplement Figure S1d). ThT fluorescence increased during 
this period from ca 50 AU up to a maximum of 350 AU at 
T=15min. for one replicate (Supplement Figure S2e). TEM at 
T=0 revealed negatively stained fibrils (width 6.21±0.78 nm). 
Between 15-45min. particles of diameter 0.8, 1.1, 1.4, 1.7, 2.2 
and 3.2 µm were observed while the range of particle sizes 
increased significantly during the final 15min. period to include 
particles of sub-nanometre, 0.02 and 0.75 nm, nanometre, 
ca 1.0, 2.0, 35.0, 40.0, 94.0, 379.0, 625.0 and 686.0 nm and 
micrometre, 1.0, 3.8 µm diameters. At T=30min. there were 
Figure 6A-J. Electron micrographs of 5μM IAPP1-37 
prepared in physiological Krebs Henseleit (KH) medium at 
pH 7.40±0.05 following 0, 30 or 60min. at 37°C. Treatments 
were prepared in the absence (A & B) or presence of 5μM 
Al(III) (C & D), Fe(III) (E & F), Cu(II) (G & H) or Zn(II) 
(I & J), containing KH medium only (A, C, E, G & I) or KH 
medium including 1mM citrate (B, D, F, H & J). Amyloid 
fibril formation is shown at 30min. for all treatments, except 
where negative staining was observed at T=0 (J) or 60min. 
(F). Asterisk indicates the position of the magnified insert. 
Magnification X 80 K (A), X 60 K (B–J). All scale bars 500 nm.
TEM revealed fibril-like material which was not negatively-
stained. After 30min. a sub-nanometre particle of ca 0.6 nm 
was observed as well as particles of 1, 550, 650 and 990 nm. 
TEM at 30min. revealed non-negatively-stained fibril-like 
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clear negatively-stained fibrils while at T=60min. no fibril-like 
deposits were observed by TEM (Figure 6E).
When these experiments were repeated in the presence of 
1 mM added citrate and compared to data in the absence of 
citrate the particle sizes were reduced across the full 60min. 
time period. ThT fluorescence was unaffected by the pres-
ence of citrate while TEM showed no deposits at T=0, dense 
non-negatively-stained fibril-like structures at T=30min. and 
similarly dense but negatively-stained fibrils (width 10.61±1.72 
nm) at T=60min. (Figure 6F).
Discussion
Metals and IAPP 
The dilution of a 200 µM stock of IAPP into a physiologically-
relevant medium to a final peptide concentration of 5 µM 
following mixing by vortexing and incubation for 4d at 37°C 
resulted in ThT fluorescence of 60-80 AU and indicated the 
formation of β sheets of this amyloidogenic peptide. The 
additional presence of up to 10 µM Al(III) had no significant 
influence upon ThT fluorescence even when the period of 
incubation was extended to 36d. Both Zn(II) and Cu(II) re-
duced ThT fluorescence of 5 µM IAPP only treatments and 
significantly so from only 1 µM added metal. Both metals at 
sub-stoichiometric concentrations prevented IAPP from form-
ing β sheets while Cu(II) also abolished the ThT fluorescence 
of β sheets of IAPP pre-formed in the absence and presence 
of added Al(III).
Previous research on IAPP showed that in the presence of 
stoichiometric excesses of metal, Al(III) and Zn(II) increased, 
Cu(II) decreased and Fe(III) had no influence upon ThT fluores-
cence under near-physiological conditions [3]. The influence 
of Cu(II) in preventing IAPP from forming β sheet structures 
has since been confirmed [5-8]. However, subsequent research 
for Zn(II), under experimental conditions further from physi-
ological, showed that significant excesses of Zn(II) reduced 
ThT fluorescence of IAPP [5]. Herein we report the first data for 
stoichiometric and sub-stoichiometric concentrations of met-
als and while we confirmed the inhibitive action of Cu(II), and 
to a lesser extent Zn(II) we did not see any influence of Al(III). 
Seeded aggregation of ProIAPP
ProIAPP1-48 at a concentration of 35 µM is mildly amyloido-
genic forming ThT-reactive amyloid, ca 20 AU, after incuba-
tion under near-physiological conditions for 600s. Seeding 
of this preparation of ProIAPP1-48 with ‘seeds’ prepared from 
ProIAPP1-48 or ProIAPP1-48 in the presence of equimolar Al(III), 
Zn(II) or Cu(II) produced statistically significant increases in 
ThT fluorescence over a further 600s incubation period and 
especially for seeds prepared from peptide only and peptide 
plus Al(III) or Zn(II). However, a ‘sham’ seed composed of only 
physiological buffer also resulted in a statistically significant 
increase in ThT fluorescence, the same as the peptide-Cu(II) 
seed but significantly lower than solutions seeded with ProI-
APP1-48 only or peptide plus Al(III) or Zn(II). The result of the 
sham seeding suggested that simple disruption and mixing 
of the ProIAPP1-48 was sufficient to induce further aggregation 
of the peptide over the short term and that the increase in 
ThT fluorescence observed for the peptide-Cu(II) seed was a 
mixing phenomenon.
The seeding effects seen for ProIAPP1-48 and peptide plus 
Al(III) or Zn(II) were also observed for similar preparations 
which had been aged for 7d. However, incubation for 14d 
and thereafter 49d negated all seeding effects and the high-
est ThT fluorescence was observed in the unseeded peptide 
preparation. Negatively stained fibrils were observed by TEM 
in all treatments after incubation for 49d. There were clear 
differences in fibril morphologies between the different 
seeded treatments which though suggesting that seeding 
was influential the influences were not seemingly related to 
ThT fluorescence. In summary these results have suggested 
that while seeding amyloid preparations can catalyse the 
formation of ThT-reactive amyloid in the short term some of 
the catalysis can be attributed to simple mixing phenomena 
and, importantly, the catalytic effects are relatively short-lived, 
at least with respect to formation of ThT-reactive amyloid.
Seeding of amyloid aggregation has been implicated in 
a number of amyloid-related pathologies [12,13]. However, 
there are very few studies in relation to self-seeding of IAPP 
[14] and no previous research on ProIAPP1-48. A previous study 
on IAPP suggested that seeding abolished a lag phase in 
amyloid formation without influencing total amyloid forma-
tion [14] and we observed something similar for ProIAPP1-48 
herein. However, ‘lag’ phases in amyloid formation are rarely 
observed under-near physiological conditions [4,15] and 
what we observed were increases in the rate of formation of 
β sheets of amyloid which also occurred, if to a lesser extent, 
following sham seeding. The latter are rarely used controls in 
previous studies on amyloid seeding. While different seeding 
environments resulted in different fibril morphologies after 
incubation for 49d at 37°C they did not result in different 
ThT-reactive fluorescence, with the exception of the Cu(II)-
ProIAPP1-48 seed which resulted in significantly lower ThT fluo-
rescence as might be expected from the additional presence 
of Cu(II) in the assay [4]. These data tend to cast some doubt 
over a significant role for self-seeding in the formation of β 
sheets of ProIAPP1-48 in relation to their putative cytotoxicity 
in type 2 diabetes mellitus. 
Aggregation of IAPP 
Since machine mixing of amyloid preparations prior to inves-
tigating their aggregation phenomena may be somewhat 
artificial in relation to what happens in vivo when concentrated 
peptide preparations are released into various extracellular 
milieus the aggregation of IAPP was investigated without 
any prior mixing. It was intriguing for IAPP only (Al(III), Cu(II), 
Zn(II) or Fe(III) not added to physiological media) that during 
the first 15min. (during which one assumed that the peptide 
stock diluted into the physiological medium) only micron-
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sized particles were observed by DLS and while they were 
accompanied by a strong ThT fluorescence there were no 
fibril-like materials observed by TEM for this period. Over the 
next 30min. a wide range of particle sizes were identified by 
DLS and included both sub-micron and micron-sized peaks 
which together seemed to indicate de novo aggregation 
phenomena though the fibril-like materials identified by TEM 
were not negatively stained. This was also true of fibril-like 
materials identified at T=60min. and DLS data suggested 
some disaggregation of amyloid aggregates during the final 
period of the 60 min. assay. When these experiments were 
repeated in media which additionally included 1 mM citrate 
there were some clear differences including overall reductions 
in the size of amyloid aggregates which were accompanied 
by statistically significant (P<0.05) increases in ThT fluores-
cence and the distinct presence of negatively-stained fibrils. 
These fibrils were significantly wider (9.57 against 7.74 nm) 
than in the absence of citrate. The changes caused by citrate 
must be attributable to the binding of low concentrations of 
contaminating metals, these metals seemingly promoting 
the rapid aggregation of non-negatively stained amyloid.
The presence of equimolar Al(III) appeared to both slow 
down aggregation of the peptide and limit the range of particle 
sizes. There were small increases in ThT fluorescence and these 
were accompanied by early observations of negatively-stained 
fibrils of mean diameter of only 4.37nm. The additional pres-
ence of citrate while having no clear influence upon particle 
sizes or ThT fluorescence did result in fibrillar materials which 
were not negatively-stained and were significantly wider at 
ca 9nm. Equimolar Cu(II) produced the expected reductions 
in ThT fluorescence which were accompanied by evidence 
of slow aggregation kinetics involving a wide range of par-
ticle sizes. The fibril-like materials viewed by TEM were not 
negatively stained and the additional presence of citrate 
while not affecting fibril morphology did appear to signifi-
cantly increase the rate of aggregation of all structures such 
that there were none visible to DLS (<6 µm) or TEM at T=60 
minutes. These changes were accompanied by significant 
increases in ThT fluorescence presumably indicating binding 
of Cu(II) by citrate. The presence of equimolar Zn(II) resulted 
in both nanoscale and micron-sized particles of IAPP almost 
from T=0 with these particles being identified throughout 
the 60min. assay. The aggregation phenomena were accom-
panied by low but slowly increasing ThT fluorescence as well 
as non-negatively-stained fibrillar materials at T=30 and 60 
minutes. The additional presence of citrate, which might be 
expected to bind Zn(II), resulted in non-significant increases 
in ThT fluorescence and of most interest the presence of 
negatively-stained fibrils at both T=0 and T=30 minutes. 
Equimolar Fe(III) resulted in almost exclusively micron-sized 
particles for the first 45min. and observations by TEM revealed 
negatively-stained fibrils at both 0 and 30minutes. The early 
presence of negatively-stained fibrils was further supported 
by an increase in ThT fluorescence during the first 15min. 
period. During the final 15min. period of the assay a range 
of sub-micron particles were observed by DLS which sug-
gested either de novo aggregation of monomeric peptide or 
potentially dissolution of micron-sized peptide aggregates. 
Interestingly the additional presence of citrate reduced the 
average particle size over the whole assay period without 
influencing ThT fluorescence though under these conditions 
negatively-stained fibrils, and hence assumed to be β-pleated 
sheet structures, were only visible by TEM at 60min. and not 
at either of the earlier time points.
We are not aware of any other research in which the ag-
gregation of IAPP was followed by 3 different techniques for 
the first 60min. after an IAPP stock was diluted into a near-
physiological milieu without additional mixing. It is probably 
true to say that such data do not exist for any amyloid-forming 
peptide and especially for media including physiologically-
relevant concentrations of metals. There are data which 
suggest that a sub-stoichiometric concentration of Cu(II) 
incubated with IAPP for 48h at room temperature reduced 
the size of IAPP particles from predominantly micron-sized 
to predominantly sub-micron [9] and the slower aggregation 
kinetics observed in our equimolar Cu(II)-IAPP preparations 
could support such an influence of Cu(II) on IAPP particle 
sizes. Overall the data suggest that equimolar Al(III), Fe(III) 
and Zn(II) all accelerated the aggregation of ProIAPP1-48 to-
wards micron-sized particles or clusters while Cu(II) may have 
had the opposite effect. These qualitative observations will 
require confirmation in future research and significantly in 
preparations where metals are also present to excess. Perhaps 
more significant physiologically was that metals changed the 
morphologies of the resultant fibrillar materials producing 
both a range of fibril diameters, with Al(III) having the most 
dramatic effect, and negatively-stained and non-negatively 
stained structures.
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